3[1]LEWIS BE,WALLIS DE,HURSTING MJ,et al.Effects of argatroban therapy,demographic variables,and platelet count on thrombotic risks in heparin-induced thrombocytopenia[J].CHEST,2006,129:1407 1416.
4[2]MATTHAI WH,HUSTING MJ,LEWIS BE,et al.Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia[J].Thromb Res,2005,116:121-126.
5[3]LEVINE RL,HURSTING MJ,McCOLLUM D.Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction[J].CHEST,2006,129:1167 1175.
6[4]WARKENTIN TE,GREINACHER A.Heparin-induced thrombocytopenia:recognition,treatment,and prevention:the aeventh ACCP conference on antithrombotic and thrombolytic therapy[J].CHEST,2004,126:311S-337S.
2LLOYD- JONES D, ADAMA RJ,BROWN TM,et al. Heartdisease and stroke statistics~2010 update : A report fromthe American heart association[ J]. Circulation,2010,121 :e46-e215.
3SUGG RM,PARY JK, UCHINO K,et al. Argatroban tPAstroke study ; study design and results in the first treated co-hort f J]. Arch Neurol. 2013,63(7) : 1057-1062.
4WALENGA JM,FASANELLA AR,LOUIS R,et al. Coagula-tion laboratory testing in patients treated with argatroban.Semin Thromb Hemost 1999,25( suppl 1) :61-66.
